
GeneDx Holdings Corp.
GeneDx Holdings Corp. (WGS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · WGS · as of Jun 9, 2026
Key Statistics
Explore GeneDx Holdings Corp. Data
wgs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 90.9%
The WGS analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $96.43, representing +86.16% upside from the current price of $51.80.
Competitors & Peers
wgs competitorsStock Performance
Full HistoryAbout GeneDx Holdings Corp.
GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence a…
what is genedx holdings corp. · wgs stock overview · genedx holdings corp. company profile · who is genedx holdings corp. ceo · wgs NASDAQ · genedx holdings corp. headquarters · genedx holdings corp. business segments
About Stock Overview & Key Data
GeneDx Holdings Corp. (WGS) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Nov 4, 2020. As of the latest trading session, WGS stock price is $51.80, with a market capitalization of $1.5B. The stock has returned -28.47% over the past 12 months and -60.17% year-to-date.
According to 11 Wall Street analysts, the consensus rating for GeneDx Holdings Corp. stock is Buy, with an average 12-month price target of $96.43. In fiscal year 2025, GeneDx Holdings Corp. reported revenue of $427.5M and net income of -$21.0M. For detailed data — including GeneDx Holdings Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, GeneDx Holdings Corp. (WGS) stock price is $51.80. The stock is traded on NASDAQ under the ticker symbol WGS. The 52-week range is $32.21 – $170.87.